×
About 614 results

ALLMedicine™ Paronychia Center

Research & Reviews  295 results

Retronychia: A Literature Review.
https://doi.org/10.7547/17-155
Journal of the American Podiatric Medical Association; Au AS, Leung WY et. al.

Jul 30th, 2020 - Retronychia is an uncommonly reported condition among the category of nail pathologies. It often presents mimicking similar nail disorders, such as onychocryptosis, onychomycosis, and paronychia. This pathologic condition has recently seen an incr...

Treatment of MEK inhibitor-induced paronychia with doxycycline.
https://doi.org/10.1111/pde.14276
Pediatric Dermatology REFERENCES; Sun Q, Antaya RJ

Jul 8th, 2020 - A 12-year-old girl with neurofibromatosis type 1 and a large facial plexiform neurofibroma had been participating in a selumetinib clinical trial for the past 5 years. Despite decreased tumor size, she developed recalcitrant selumetinib-induced pa...

Fingertip Infections.
https://doi.org/10.1016/j.hcl.2020.03.004
Hand Clinics; Barger J, Garg R et. al.

Jun 25th, 2020 - The fingertip is the most common site of infections in the hand, which frequently are encountered by surgeons, dermatologists, and emergency and primary providers. Their mismanagement may have serious consequences. This review discusses the unique...

Nevoid melanoma and eruptive nevi from erlotinib.
https://www.ncbi.nlm.nih.gov/pubmed/32815691
Dermatology Online Journal; Seidman JS, Eichenfield DZ et. al.

Jun 14th, 2020 - Cutaneous side effects such as acneiform eruption, xerosis, and paronychia are frequently observed in patients undergoing treatment with epidermal growth factor receptor (EGFR) inhibitors for non-small cell lung cancer and other solid tumors. Inte...

Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth f...
https://doi.org/10.1016/j.jaad.2020.06.010
Journal of the American Academy of Dermatology; Olamiju B, Bhullar S et. al.

Jun 11th, 2020 - Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies.|2020|Olamiju B,Bhullar S,Coleman EL,Leve...

see more →

Guidelines  1 results

Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibito...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532717
Drugs Califano R, Tariq N et. al.

Jul 18th, 2015 - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) such as gefitinib, erlotinib, and afatinib are standard-of-care for first-line treatment of EGFR-mutant advanced non-small cell lung cancer (NSCLC). These drugs have a prove...

see more →

Clinicaltrials.gov  301 results

Retronychia: A Literature Review.
https://doi.org/10.7547/17-155
Journal of the American Podiatric Medical Association; Au AS, Leung WY et. al.

Jul 30th, 2020 - Retronychia is an uncommonly reported condition among the category of nail pathologies. It often presents mimicking similar nail disorders, such as onychocryptosis, onychomycosis, and paronychia. This pathologic condition has recently seen an incr...

Treatment of MEK inhibitor-induced paronychia with doxycycline.
https://doi.org/10.1111/pde.14276
Pediatric Dermatology REFERENCES; Sun Q, Antaya RJ

Jul 8th, 2020 - A 12-year-old girl with neurofibromatosis type 1 and a large facial plexiform neurofibroma had been participating in a selumetinib clinical trial for the past 5 years. Despite decreased tumor size, she developed recalcitrant selumetinib-induced pa...

Fingertip Infections.
https://doi.org/10.1016/j.hcl.2020.03.004
Hand Clinics; Barger J, Garg R et. al.

Jun 25th, 2020 - The fingertip is the most common site of infections in the hand, which frequently are encountered by surgeons, dermatologists, and emergency and primary providers. Their mismanagement may have serious consequences. This review discusses the unique...

Nevoid melanoma and eruptive nevi from erlotinib.
https://www.ncbi.nlm.nih.gov/pubmed/32815691
Dermatology Online Journal; Seidman JS, Eichenfield DZ et. al.

Jun 14th, 2020 - Cutaneous side effects such as acneiform eruption, xerosis, and paronychia are frequently observed in patients undergoing treatment with epidermal growth factor receptor (EGFR) inhibitors for non-small cell lung cancer and other solid tumors. Inte...

Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth f...
https://doi.org/10.1016/j.jaad.2020.06.010
Journal of the American Academy of Dermatology; Olamiju B, Bhullar S et. al.

Jun 11th, 2020 - Management of paronychia with pseudopyogenic granulomas secondary to epidermal growth factor receptor inhibitors: An assessment of topical timolol and the need for multiple medical and procedural therapies.|2020|Olamiju B,Bhullar S,Coleman EL,Leve...

see more →

News  15 results

Subungual Hemorrhage From an Epidermal Growth Factor Receptor Inhibitor
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor?channel=44
Josh A. Hammel, MD, Dean Elhag, MD et. al.

Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.

Green thumbnail
https://www.mdedge.com/familymedicine/article/206700/infectious-diseases/green-thumbnail?channel=234
MDedge Family Medicine;

Aug 22nd, 2019 - The patient was given a diagnosis of green nail syndrome (GNS), an infection of the nail bed caused by Pseudomonas aeruginosa. These bacteria produce pyocyanin, a blue-green pigment that discolors the nail.

If Not Fungal Infection, Then What?
https://www.mdedge.com/clinicianreviews/article/80235/dermatology/if-not-fungal-infection-then-what/page/0/1

Feb 5th, 2014 - DISCUSSION This problem—chronic paronychia (also known as chronic candidal paronychia)—is not well known outside derm circles. It's even a bit of a mystery within the specialty, although we see it often enough to become comfortable with its diagno.

Patient's Condition is "All Thumbs"
https://www.mdedge.com/clinicianreviews/article/76751/dermatology/patients-condition-all-thumbs
Joe R. Monroe, MPAS, PA

Feb 16th, 2012 - ANSWER 
The correct answer is habit-tic deformity (choice “d”), a relatively common self-inflicted condition relegated to thumbnails. Chronic candidal paronychia (choice “a”) has certain similarities to habit-tic deformity (eg, loss of connection.

see more →

Patient Education  2 results see all →